X0508 4 2025-11-21 0001348911 KalVista Pharmaceuticals, Inc. KALV 0001691102 Yea Christopher C/O KALVISTA PHARMACEUTICALS, INC 200 CROSSING BOULEVARD FRAMINGHAM MA 01702 false true false false CHIEF DEVELOPMENT OFFICER 0 Common Stock 2025-11-21 4 M 0 3750 A 224714 D Common Stock 2025-11-22 4 M 0 3125 A 227839 D Common Stock 2025-11-24 4 S 0 4331 13.4510 D 223508 D Restricted Stock Unit 2025-11-21 4 M 0 3750 0 D Common Stock 3750 48750 D Restricted Stock Unit 2025-11-22 4 M 0 3125 0 D Common Stock 3125 31250 D Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. 1/16th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date, subject to continued service through each vesting date. /s/ Benjamin L. Palleiko, Attorney-in-Fact 2025-11-26